Earnings Feed
Start Free
NEUROCRINE BIOSCIENCES INC·4

Feb 17, 5:46 PM ET

BENEVICH ERIC 4

Research Summary

AI-generated summary

Updated

Neurocrine (NBIX) CCO Eric Benevich Receives RSUs; Shares Withheld

What Happened

  • Eric Benevich, Chief Commercial Officer of Neurocrine Biosciences (NBIX), had multiple restricted stock units (RSUs) and performance RSUs (PRSUs) vest on February 12–13, 2026. In total he was credited with 65,314 shares through vesting/conversion and awards.
  • To satisfy tax withholding obligations, 12,227 shares were withheld by the company (reported as dispositions) at prices of $123.10 and $124.12, totaling $1,516,512 in withholding. After withholding, the net increase in shares to Benevich was approximately 53,087 shares.
  • These were award/vesting transactions (codes A and M for grant/conversion and F for tax withholding). No open-market sale of shares was reported — the company withheld shares to cover taxes.

Key Details

  • Transaction dates: February 12, 2026 and February 13, 2026. Filing date: February 17, 2026 (timely).
  • Withheld (disposed) shares for taxes: 12,227 shares withheld at $123.10 and $124.12; total cash value withheld ≈ $1,516,512.
  • Gross shares credited via vesting/conversion: 65,314 shares (sum of RSU/PRSU vesting and related conversions).
  • Net new shares after withholding: ~53,087 shares.
  • Notable footnotes:
    • F1: Shares were withheld by the company to satisfy tax withholding; no market sale occurred.
    • F2: PRSUs granted May 19, 2023 were certified Feb 13, 2026 and vested at 125% of target (performance payout).
    • F4–F6/F8: Describe scheduled vesting for various RSU grants (annual/monthly vesting schedules).
  • Shares owned after the transaction were not specified in the excerpt provided.

Context

  • These filings reflect routine equity compensation vesting and tax-withholding mechanics, not open-market purchases or discretionary insider sales. In SEC Form 4 terms: A = award/grant, M = exercise/conversion of derivative, F = shares withheld to cover taxes.
  • PRSU certification (F2) triggered a larger-than-target payout (125%), explaining the sizable award on Feb 13. Because shares were withheld by the company to satisfy taxes, this is not a market sell and does not necessarily indicate insider sentiment.